Although RMD has re-rated from its share price low of around $21.50 in October 2023, it has only just surpassed its all-time ...

Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...

This is not the only recall the company is dealing with. Philips’ Respironics business has been facing issues with some of its sleep apnea products since June 2021 when it issued a recall of 15 ...

At least two deaths and over a hundred injuries have been linked to a malfunctioning heart monitoring device from Philips and its subsidiary, Braemer. The company affirmed in a statement that that the ...

Pittsburgh’s Indian food scene is finally catching up — new and established dining spots are tapping the culture’s diversity ...

New Pittsburgh restaurateurs are dismantling the butter chicken monopoly, replacing it with dishes that embody the dynamism ...

Related: Philips recalls remote cardiac monitoring software ... improve its imaging business and restore its sleep and respiratory care business. The Philips emergency care business operates ...

The Class I recall, the FDA’s severest classification, is a correction and does not require removing devices from where they are used or sold. Philips started the recall on Nov. 20, 2024 ...

The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect cases of hidden, transient arrhythmias that may only last minutes at a time.